Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

<div>PCA and PLS-DA scores plots discriminating CRC serum samples with QD or YD from those with ND. (a) PCA: QD versus ND; (b) PCA: YD versus ND; (c) PCA: QD versus YD. (d) PLS-DA: QD versus ND; (e) PLS-DA: YD versus ND; (f) PLS-DA: QD versus YD.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 

Figure 1 | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 